Ever since Type A personality was linked to cardiovascular disease in the 1950s, it’s been known that anger raises the risk of heart attack and stroke. Now a Columbia study may explain how.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
A study of people with obstructive sleep apnea suggests that high CPAP pressures may explain why the machines do not lower a patient’s risk of heart disease.
A study revealing new structural details of an intracellular channel that controls muscle contraction may lead to new drugs for heart and muscle diseases.
A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy.
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Transcatheter aortic valve replacement (TAVR) is a viable alternative to open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery.
Researchers are collaborating with the NBA to create a new standard in the detection and reduction of cardiac risk among professional basketball athletes.
Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a new study from Columbia researchers.